N-Power Medicine
N-Power Medicine leverages a network of community oncology centers equipped with qualified staff to identify suitable patients for research studies, enabling pharmaceutical companies and researchers to conduct trials faster and potentially reach a more diverse pool of participants.
Series B
Latest Funding Stage
2024-07-01
Funding Date
60
Employees
United States
Location
Redwood City, California
City & State
Sales-Ready Summary
NPower Medicine recently raised a Series B and is hiring for Data Science, Engineering, and IT roles, indicating they are expanding their technical capabilities and infrastructure. Companies offering AI solutions, data analytics tools, or IT infrastructure services should reach out to key decision-makers in their IT and Engineering departments.
Key Contacts
Open Positions
View Careers PageHiring For
Similar Startups
Eikon Therapeutics
Eikon Therapeutics is a biopharmaceutical company that focuses on developing innovative technologies for drug discovery. The company utilizes advanced live-cell resolution microscopy and engineering to identify and create new therapeutic candidates. Eikon Therapeutics aims to enhance the understanding of biological processes at a cellular level,supporting targeted treatment development.
Arsenale Bioyards
Arsenale is transforming biomanufacturing with a proprietary end-to-end platform that integrates advanced hardware, AI-driven software, and precision fermentation. Designed to bridge the gap from lab-scale innovation to industrial-scale production, Arsenale enables industries like food, chemicals, and materials to seamlessly develop and scalebio-based alternatives to petrochemicals and animal-derived products.
EvidenceHunt
EvidenceHunt is an AI-powered research assistant developed by medical professionals for healthcare research. Our focus is on delivering tools that streamline gathering and analyzing clinical evidence. With features like AI Chat for interactive queries and comprehensive Direct Search options, EvidenceHunt allows precise data retrieval andanalysis.
Avitia
Avitia improves cancer treatment via advanced molecular testing solutions. Avitia offer testing tools for use on-site, bioinformatics driven by AI, and actionable insights aimed at enhancing patient outcomes. Avitia offerings comprise pre-prepared NGS panels, simplified reporting mechanisms, and cooperative diagnostic platforms.